WALTHAM, Mass., Jan. 05, 2016 (GLOBE NEWSWIRE) — AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) today announced that William Heiden, AMAG’s chief executive officer, will present at the 34th Annual J.P. Morgan Healthcare Conference on Wednesday, January 13, 2016 at 10:00 a.m. Pacific Time. The session will include a company presentation followed by a question and answer period.
A live audio webcast of the company’s presentation and the following breakout session along with the accompanying slide presentation will be accessible through the Investors section of the company’s website at www.amagpharma.com. Following the conference, the webcast will be archived on the AMAG Pharmaceuticals, Inc. website until February 12, 2016.
AMAG Pharmaceuticals uses its business and clinical expertise to develop and commercialize products that provide clear benefits and improve people’s lives. Based in Waltham, Massachusetts, AMAG has a diverse portfolio of products in the areas of maternal health, anemia management and cancer supportive care. AMAG continues to work to expand the impact of these and future products for patients by delivering on its growth strategy, which includes organic growth, as well as the pursuit of products and companies that align with AMAG’s existing therapeutic areas or those that could benefit from its proven core competencies. For additional company information, please visit www.amagpharma.com.
AMAG Pharmaceuticals, Inc. Contact:
Manager, Corporate Communications & External Affairs
AMAG Pharmaceuticals, Inc.